Table 5.
TNM stage II | TNM stage III | TNM stage IV | |||||||
---|---|---|---|---|---|---|---|---|---|
Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | |
NLR | 0.765 | 0.32–1.827 | 0.547 | 0.467 | 0.266–0.818 | 0.008 | 0.156 | 0.092–0.265 | < 0.001 |
CEA | 0.424 | 0.182–0.987 | 0.047 | 0.342 | 0.188–0.621 | < 0.001 | 0.221 | 0.124–0.394 | < 0.001 |
CA19-9 | 0.87 | 0.364–2.08 | 0.755 | 0.406 | 0.234–0.703 | 0.001 | 0.28 | 0.165–0.476 | < 0.001 |
CA72-4 | 1.238 | 0.42–3.65 | 0.699 | 0.4 | 0.216–0.741 | 0.004 | 0.228 | 0.126–0.414 | < 0.001 |
For multiple logistic regression analyses the reference category is TNM stage I. The reference of NLR, CEA, CA19-9 and CA72-4 was NLR ≥ 2.91, CEA ≥ 4.34, CA19-9 ≥ 18.69 and CA72-4 ≥ 6.96.
TNM tumor-node-metastasis, NLR neutrophil–lymphocyte ratio, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19-9, CA72-4 carbohydrate antigen 72–4.